Dehydroepiandrosterone (DHEA) against vaginal atrophy.
Phase of Trial: Phase III
Latest Information Update: 14 Jun 2017
At a glance
- Drugs Prasterone (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- Sponsors Endoceutics
- 29 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.
- 29 May 2012 Actual patient number added 450 according to ClinicalTrials.gov.
- 29 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.